As shown in Table 1, high serum IL-18 levels were significantly associated with poor prognostic factors, such as hormone receptor negativity (p < 0.001), larger tumor size (p = 0.005), nodal involvement (p = 0.021), and a higher Ki67 positivity (p = 0.013). This evidence concerns the gene MKI67 and neoplasm.